Las Vegas, NV -- (SBWIRE) -- 01/04/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Avanir Pharmaceuticals Inc(NASDAQ:AVNR), Aeropostale Inc (NYSE: ARO), Keryx Biopharmaceuticals (NASDAQ:KERX), Monster Worldwide, Inc.(NYSE:MWW)
Avanir Pharmaceuticals Inc(NASDAQ:AVNR) was a volume gainer of 2.30 million shares and the average volume of the stock remained 3.09 million shares. The stock opened the session at $3.33 and finished at the end of the day at $3.21 and the stock plunged -4.46% .The market capitalizations of the stock remained 488.28 million. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. Avanir Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California.
Has AVNR Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Aeropostale Inc (NYSE: ARO) exchanged 2.27 million shares and the average volume remained 3.13 million shares. The stock closed the session at $9.08 with the drop of -0.11%. Aéropostale, Inc., together with its subsidiaries, operates as a mall-based specialty retailer of casual apparel and accessories. It provides a collection of apparel, including graphic t-shirts, tops, bottoms, sweaters, jeans, outerwear, and accessories for 14 to 17 year-old young women and men. Aéropostale, Inc. was founded in 1987 and is headquartered in New York, New York.
Why Should Investors Buy ARO After the Recent Fall? Just Go Here and Find Out
Keryx Biopharmaceuticals (NASDAQ:KERX) decreased -2.47% and its closing price was $12.63. The volume of the stock was 2.24 million shares and the average volume remained 2.34 million shares. The market capitalization of the stock remained 1.04 billion. The beta of the stock remained 3.93. Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in New York, New York.
Will KERX Get Buyers Even After The Recent Rally? Find Out Here
Monster Worldwide, Inc.(NYSE:MWW) exchanged 2.18 million shares in the previous trading session, and its average trading remained 2.50 million shares. MWW dropped -0.98% and it closed the trading at $7.06. The market capitalization of the stock remained 798.02 million. Monster Worldwide, Inc., together with its subsidiaries, provides online and mobile employment solutions worldwide. It offers customized solutions and technologies across a range of public and private sectors. The company was founded in 1967 and is headquartered in New York, New York.
Has MWW Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)